Volume 91 Issue 15 | p. 6 | News of The Week
Issue Date: April 15, 2013

GlaxoSmithKline Goes Beyond Pharmaceuticals

Medicine: Firm launches effort to harness the body’s neural impulses to fight disease with “electroceuticals"
Department: Business
Keywords: pharmaceuticals, devices, neuroscience, nanotechnology, R&D

GlaxoSmithKline wants to explore whether diseases can be treated and health restored by modulating neural impulses in the body. Last week the British drug company announced it will support a nascent field it calls “electroceuticals” with funds for 20 external labs and a $1 million prize.

“We see this as a new treatment modality—something in parallel with small molecules, protein therapeutics, and vaccines—by which we hope we can treat diseases,” says Kristoffer Famm, . . .

To view the rest of this content, please log in with your ACS ID.

Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society